PE-22-28peptidebuy The PE-22-28 peptide is a synthetic derivative of the naturally occurring peptide spadin, emerging as a significant area of interest in scientific research. This heptapeptide, comprising seven amino acids, is primarily known for its potent inhibitory action on the TREK-1 potassium channel, exhibiting an IC50 value of 0.12 nMPE 22-28 | TREK-1抑制剂. This mechanism suggests PE-22-28's potential to influence mood regulation and cognitive functions, making it a subject of investigation for conditions such as depression, anxiety, and neurodegenerative diseases. Research indicates that PE-22-28 may also play a role in accelerating wound healing by stimulating collagen production and promoting tissue regeneration.
At its core, PE-22-28 functions as a selective antagonist of TREK-1 (TWIK-related acid-sensitive potassium channel 1).PE 22-28 TREK-1 channels are widely expressed in the nervous system and play a crucial role in regulating neuronal excitability. By inhibiting these channels, PE-22-28 can modulate neuronal firing patterns, which is believed to underlie its observed effects on mood and cognition. Studies have shown that PE-22-28 can increase neurogenesis and synaptogenesis, indicated by elevated levels of postsynaptic density protein 95 (Psd-95)作者：A Djillani·2019·被引用次数：42—Similar to spadin, hippocampal neurogenesis is increased as revealed by BrdU (5-. Bromo-2´-Deoxyuridine) labeling with a prominent effect of G/A-PE 22-28(Table .... This enhancement of neural connections is vital for learning, memory, and overall brain health. Furthermore, PE-22-28 has demonstrated a reduction in apoptotic cell death in rodent models of ischemia, highlighting its neuroprotective capabilitiesPE 22-28 Supplier | CAS 1801959-12-5 | PE22-28.
The research surrounding PE-22-28 points to a multifaceted range of potential therapeutic applications, predominantly within the realm of neurological and psychiatric healthPE-22-28 is a peptide that aids in treating mood, depression and cognition. PE 22-28 is a synthetic derivative of the naturally occurring protein called Spadin..
* Mood Regulation and Depression: A significant focus of PE-22-28 research is its antidepressant activity.PE 22-28 is a TREK-1 inhibitor with IC 50 value of 0.12 nM. PE 22-28 also is a 7 amino-acid peptide that is used as a core sequence for preparing analogs. By modulating TREK-1 channels, the peptide is thought to help stabilize mood and alleviate symptoms of depression.PE 22-28 is a potent inhibitor of potassium channel subfamily K member 2/TREK-1(IC50 = 0.12 nM). In rodent models of ischemia PE 22-28 reduces apoptotic death ... Some experts consider PE-22-28 among the newest peptides showing promise for treating major depressive disorder.Understanding PE 22 28 Anxiety
* Cognitive Enhancement: PE-22-28 has been investigated for its ability to improve cognitive functions, including memory, decision-making, and focus.PE 22-28 | TREK-1 Inhibitor Its role in promoting neurogenesis and synaptogenesis contributes to these potential cognitive benefits.
* Anxiety Reduction: Beyond depression, PE-22-28 is also being studied for its anxiolytic effects, suggesting it could help reduce anxiety and promote a sense of calm.
* Neuroprotection and Stroke Recovery: The peptide's demonstrated neuroprotective properties, including reducing cell death after ischemic events, suggest a role in managing stroke recovery and potentially other neurodegenerative conditions.PE 22-28(4 µg/kg for four days) increases neurogenesis and the levels of postsynaptic density protein 95 (Psd-95), a measure of increased synaptogenesis, in ...
* Wound Healing: Emerging research indicates PE-22-28's capacity to accelerate wound healing by fostering collagen production and enhancing tissue regeneration, alongside its anti-inflammatory effects at wound sites作者：A Djillani·2019·被引用次数：42—Similar to spadin, hippocampal neurogenesis is increased as revealed by BrdU (5-. Bromo-2´-Deoxyuridine) labeling with a prominent effect of G/A-PE 22-28(Table ....
PE-22-28 is currently considered a research peptide, and its development is primarily driven by scientific studies exploring its efficacy and safety. While it is synthesized as a core peptide sequence (GVSWGLR), it also serves as a foundational element for creating various analogs through chemical modifications and amino acid substitutions. This approach aims to further optimize its stability and therapeutic potential. Information regarding specific dosage protocols and potential side effects is still largely derived from ongoing research and clinical investigations.
The PE-22-28 peptide represents a promising area of scientific inquiry, particularly for its impact on TREK-1 channels and subsequent influence on neurological and mood-related functions.Peptide PE-22-28 Its potential applications in treating depression, enhancing cognition, reducing anxiety, and promoting neuroprotection are subjects of active research. As a synthetic derivative of spadin, PE-22-28's ability to modulate crucial neural pathways positions it as a peptide with significant therapeutic potential, warranting continued investigation into its full spectrum of benefits and applications.2025年4月21日—By inhibiting the TREK-1 receptor in research subjects, the PE-22-28 peptidemay influence mood regulation and treat neural inflammation. What ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.